All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or HealthTree for Multiple Myeloma.

The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your Multiple Myeloma Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The Multiple Myeloma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Multiple Myeloma Hub cannot guarantee the accuracy of translated content. The Multiple Myeloma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
Visit:
ALL Hub

ALL Hub

AML Hub

AML Hub

GvHD Hub

GvHD Hub

Lupus Hub

Lupus Hub

Lymphoma Hub

Lymphoma Hub

MPN Hub

MPN Hub

PsOPsA Hub

PsOPsA Hub

LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.
Steering CommitteeAbout UsNewsletterContact
TypesTherapeuticsCongressesTrialsExpert OpinionsDRUG UPDATES
2020-06-17T07:30:06.000Z

How to diagnose and treat smoldering myeloma in 2020

By Claire Baker, Amalia Zachariadis
Featured
Shaji Kumar
Jun 17, 2020
Share:

Bookmark this article

During the 25th Congress of the European Hematology Association (EHA), the Multiple Myeloma (MM) Hub spoke to Shaji Kumar, Mayo Clinic, Rochester, US, about how to diagnose and treat smoldering myeloma in 2020.

The biology of myeloma progression, from smoldering myeloma to overt disease, has become better understood in the last decade. Here, the key points from a large International Myeloma Working Group study, evaluating the risk factors for progression to MM, are discussed. Shaji Kumar outlines how the findings from this risk stratification study are used today in clinical practice.

How to diagnose and treat smoldering myeloma in 2020

More about...
EHAEHA 2020Smoldering multiple myeloma

Your opinion matters

As a result of this content, I commit to reviewing the CARTITUDE clinical program to guide my understanding of cilta-cel in clinical practice.
27 votes - 7 days left ...

Related articles

Add bookmark

ASH 2020| Practice-changing and breakthrough abstracts in multiple myeloma

The Multiple Myeloma Hub attended the virtual 62nd ASH Annual Meeting & Exposition, December, 5–8 2020, and has developed two downloadable resources, which provides...

Feb 20, 2021
Add bookmark

ASH 2020| Practice-changing and breakthrough abstracts in multiple myeloma

The Multiple Myeloma Hub attended the virtual 62nd ASH Annual Meeting & Exposition, December, 5–8 2020, and has developed...

Feb 20, 2021
Add bookmark

Monthly theme | An introduction to patient reported outcomes (PROs) and quality of life (QoL) assessments in multiple myeloma 

This article will introduce PROs and QoL assessments in MM, as well as set the scene for the content that will be following...

Aug 7, 2019
Add bookmark

Monthly theme | An introduction to patient reported outcomes (PROs) and quality of life (QoL) assessments in multiple myeloma 

This article will introduce PROs and QoL assessments in MM, as well as...

Aug 7, 2019

Newsletter

Subscribe to get the best content related to multiple myeloma delivered to your inbox